Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.
- Resource Type
- journal article
- Authors
- Escudier, Bernard; Porta, Camillo; Bono, Petri; Powles, Thomas; Eisen, Tim; Sternberg, Cora N; Gschwend, Jürgen E; De Giorgi, Ugo; Parikh, Omi; Hawkins, Robert; Sevin, Emmanuel; Négrier, Sylvie; Khan, Sadya; Diaz, Jose; Redhu, Suman; Mehmud, Faisal; Cella, David
- Source
- Journal of Clinical Oncology; 5/10/2014, Vol. 32 Issue 14, p1412-1418, 7p
- Subject
- Language
- ISSN
- 0732183X